Document is current
Any future updates will be listed below
-
Authors
Rojas, Dante E.
McCartney, Mitchell M.
Borras, Eva
Hicks, Tristan L.
Lam, Tiffany T.
Kenyon, Nicholas J.
Davis, Cristina E.
-
Funding
Funding for this research was provided by:
University of California Tobacco-Related Disease Research Program (T31IR1614)
University of California Tobacco-Related Disease Research Program (T31IR1614)
National Center for Advancing Translational Sciences (U01-TR004083)
National Center for Advancing Translational Sciences (U01-TR004083)
NIH (P30-ES023513)
NIH (P30-ES023513)
U.S. Department of Veterans Affairs (I01-BX004965)
Office of the President, University of California (R02CP7431)
U.S. Department of Energy (DE-NA0003525)
- License Information
-
More Information
Article History
Received: 13 October 2024
Accepted: 9 February 2025
First Online: 21 February 2025
Declarations
:
: This study was conducted in accordance with the Declaration of Helsinki. This study was approved by the University of California, Davis Institutional Review Board (Protocol #1671798). Informed consent was provided by each volunteer prior to participating in the study. Consent for publication is not applicable.
: D.E.Rojas, M.M.McCartney, E.Borras, T.L.Hicks, and T.T.Lam have no conflicts of interest to report. N.J.Kenyon reports grants from: The US National Institutes of Health (NCATS, NIEHS, Office of the Director), the University of California Office of the President, Sandia National Laboratories, US Department of Veterans Affairs, the University of California Tobacco-Related Disease Research Program; and participation in an Advisory Board to Regeneron. C.E.Davis reports grants from: The US National Institutes of Health (NCATS, NIEHS, Office of the Director), the University of California Office of the President, Sandia National Laboratories, US Department of Veterans Affairs, the University of California Tobacco-Related Disease Research Program, Detect-Ion LLC, and SensIT Ventures; licenses of IP related to this work (but not used herein) with SensIT Ventures; had travel paid to review programs by Los Alamos National Laboratory; is a Board Member of the International Association of Breath Research and Editor-in-Chief of the Journal of Breath Research; and an equity holder of SensIT Ventures.
